Malarkey, Chris - Loretto Heights College

个人简介

Ph.D., Biochemistry, Loyola University Chicago, 2008 B.S., Chemistry, Loyola University Chicago, 2003 My teaching style focuses on a discussion based classroom environment where students are actively engaged in the subject matter. I feel this teaching style made me a natural fit for the Team Based Learning method employed in the School of Pharmacy at Regis University. While in the classroom, I encourage students to look at the underlying assumptions for a particular theory that we may be working on. For example, when teaching protein/ligand binding, I ask students what are the assumptions made by a lock and key mechanism versus an induced fit model? I like to make the students aware that there are several ways of thinking about the same phenomenon. I encourage openly asking questions in my classroom as well, and I feel that this helps generate dialogue between students and therefore encourages them to critically examine key concepts in the physical sciences. In addition to teaching in the classroom, I am passionate about teaching and learning in the laboratory. I feel that the lab is where the frontiers of pharmaceutical sciences are advanced and new knowledge about disease states is obtained. Furthermore, I believe that the making discoveries in the laboratory help further the Regis University mission of the pursuit of truth. Before teaching at Regis University, I taught biochemical concepts to first year graduate students and medical students during my postdoctoral fellowship at the University of Colorado School of Medicine. During my graduate studies in chemistry, I taught general chemistry, organic chemistry, physical chemistry, and biochemistry to both undergraduate and graduate students.

研究领域

Information Theory: How do drugs interact with proteins? Bipolar Disorder: How does lithium serve as an effective therapeutic? Heart Disease: How does a mitochondrial transcription factor mutant lead to cardiomyopathies? Mitochondrial Transcription: Several disease states have altered mitochondrial transcription. Developing Autoimmune Disease Treatments: Autoimmune diseases such as lupus recognize “self” DNA as foreign pathogens. Can we exploit existing DNA binding proteins in the body as therapeutic agents? Testicular Cancer: Can we target the HMGB4/DNA interaction in chemotherapy? Understanding the Sox2/Promoter DNA mechanism: Several development diseases and cancer are associated with malfunctioning Sox2 function. Developing a greater understanding of this interaction at the molecular level could lead to novel therapeutics.

近期论文

查看导师最新文章（温馨提示：请注意重名现象，建议点开原文通过作者单位确认）

Malarkey, C.S., Gustafson, C.E., Saifee, J.F., Torres, R.M., Churchill, M.E.A., and Janoff, E.N. (2016) “Mechanism of mitochondrial transcription factor A attenuation of CpG-induced antibody production.” PloS one. 11. E0157157. Malarkey, CS, Lionetti, C, Deceglie, S, Roberti, M, Churchill, ME, Cantatore, P, Loguercio, P, Polosa, P (2016). The sea urchin mitochondrial transcription factor A binds and bends DNA efficiently despite its unusually short C-terminal tail. Mitochondrion. Apr 14;29:1-6. doi: 10.1016/j.mito.2016.04.004. [Epub ahead of print]. Sánchez-Giraldo, R., Acosta-Reyes, F.J., Malarkey, C.S., Saperas, N., Churchill, M.E.A., and Campos, J.L. (2015) “Two High-Mobility Group Box Domains Act Together to Underwind and Kink DNA.” Acta Crystallographica Section D. 71. 1423-1432. Das, C., Roy, S., Namshoshi, S., Malarkey, C.S., Jones, D.N.M., Kutateladze, T.G., Churchill, M.E.A., and Tyler, J.K. (2014) “Binding of the histone chaperone ASF1 to the CBP bromodomain promotes histone acetylation.” Proceedings of the National Academy of Sciences. 111, E1072-E1081. Wysoczynski, C.L., Roemer, S.C., Dostal, V., Barkley, R.M., Churchill, M.E.A., and Malarkey, C.S. (2013) “Reversed-phase Ion-pair Liquid Chromatography Method for Purification of Duplex DNA with Single Base Pair Resolution.” Nucleic Acids Research. 41. e194-e194. Malarkey, C.S., and Churchill, M.E.A. (2012) “The High Mobility Group Box: the Ultimate Utility Player of a Cell.” Trends in Biochemical Sciences. 37. 553-562. Malarkey, C.S., Bestwick, M., Kuhlwilm, J., Shadel, G.S., and Churchill, M.E.A. (2012) “Transcriptional Activation by Mitochondrial Transcription Factor A Involves Preferential Distortion of Promoter DNA.” Nucleic Acids Research. 40. 614-62